PATENT CLAIM ANALYSIS

Application Number: 15924831
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "060000"]

Abstract:
Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.

Claim (Index 1):
A composition comprising an effective amount of or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or vehicle.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13791205', '14730994', '14980347', '15375959', '13791744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6048033570595199
- 35 USC 102 Novelty (BERT): 0.5308084444166244
- Combined Prediction Score: 0.5974038657952303
- Mean Citation Score: 340.650774
- Max Citation Score: 356.59286000000014
- Similarity Product: 300.56112528290043

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test